You can buy or sell Capricor and other stocks, options, ETFs, and crypto commission-free!
Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. Read More The company was founded in August 2005 and is headquartered in Beverly Hills, CA.
Beverly Hills, California
52 Week High
52 Week Low
Simply Wall StFeb 19
One Thing To Remember About The Capricor Therapeutics, Inc. (NASDAQ:CAPR) Share Price
Want to participate in a short research study? Help shape the future of investing tools and receive a $20 prize! Anyone researching Capricor Therapeutics, Inc. (NASDAQ:CAPR) might want to consider the historical volatility of the share price. Volatility is considered to be a measure of risk in modern finance theory. Investors may think of volatility as falling into two main categories. The first type is company specific volatility. Investors use diversification across uncorrelated stocks to reduce this kin...
-$0.16 per share
Available Mar 28, After Hours